Publication: 262

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808
      QxMD      Google Scholar   
Citation:
Blood vol 116 (9) 1413-1421
Year:
2010
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
461  
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA032291, CA33601, U10 CA077658, CA02599, CA32291, CA41287, U10 CA035279, CA03927, U10 CA031946, U10 CA033601, CA35279, U10 CA077440, CA77440, U10 CA041287, U10 CA047559, CA47559, CA77658, CA31983, CA31946, U10 CA003927  
Corr. Author:
 
Authors:
                                 
Networks:
 
Study
CALGB-19808
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-8461
Phases:
3, N/A
Keywords:
Clinical Trials and Observations